Quick Takeaways
- Madison Avenue Partners, LP filed SCHEDULE 13G/A for Ovid Therapeutics Inc. Common Stock, par value $0.001 per share (the "Common Stock") (OVID).
- Disclosed ownership: 4%.
- Date of event: 31 Dec 2024.
Quoteable Key Fact
"Madison Avenue Partners, LP disclosed 4% ownership in Ovid Therapeutics Inc. Common Stock, par value $0.001 per share (the "Common Stock") (OVID) on 31 Dec 2024."
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original Filing| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Madison Avenue Partners, LP | 4% | 2,852,352 | 0 | 2,852,352 | /s/ Eli Samaha | Eli Samaha, as Managing Member of EMAI Management, LLC the General Partner of Madison Avenue Partners, LP | |
| Madison Avenue International LP | 4% | 2,852,352 | 0 | 2,852,352 | /s/ Eli Samaha | Eli Samaha, as Manager of Madison Avenue GP, LLC, the General Partner of Madison Avenue International LP | |
| EMAI Management, LLC | 4% | 2,852,352 | 0 | 2,852,352 | /s/ Eli Samaha | Eli Samaha, as Managing Member | |
| Madison Avenue GP, LLC | 4% | 2,852,352 | 0 | 2,852,352 | /s/ Eli Samaha | Eli Samaha, as Manager | |
| Caraway Jackson Investments LLC | 4% | 2,852,352 | 0 | 2,852,352 | /s/ Eli Samaha | Eli Samaha, as Member | |
| Eli Samaha | 4% | 2,852,352 | 0 | 2,852,352 | /s/ Eli Samaha | Eli Samaha |